Melanoma Diagnosis Linked to Increased Risk of Prostate Cancer
More than twofold increased risk of prostate cancer seen for men with first melanoma diagnosed 10 to 15 years before study recruitment
Diagnosis & Disease Information
Disparities in Use of Immunotherapies Persist After FDA Approval
Some disparities that existed before FDA approval persisted after approval, and some new disparities emerged after FDA approval.
Therapeutic Advancements Have Facilitated Surgery Optimization, ASCO Officials Report
ASCO outlined advances in oncology that were the most clinically meaningful or had the biggest scientific impact from October 2018 through September 2019.
Longer Duration of Steroids May Affect Outcomes During Anti-PD-1 Treatment
The use of steroids for the treatment of immune-related adverse events may have survival consequences.
Melanoma Staging System Updated
Key changes include new N category descriptors, more stage III subgroups, new M1D designation.
Most Melanomas Arise From New Lesions, Not Moles
The findings showed that only 29.1% of the skin cancers started in moles patients already had.
Melanoma Risk Higher in Kidney Transplant Recipients
Risk factors include older age, white race, and receiving a kidney from a living donor.
PDE5 Inhibitor Use Doesn’t Cause Melanoma
While users had an overall 11% increased risk of melanoma, there wasn’t evidence that the drugs cause melanoma.
Uptick in Melanoma Risk With PDE5 Inhibitors
Researchers say skin cancer in these patients is likely due to more sun exposure.
Researchers Calculate Inherited Cancer Risk from Genes
Estimated 33% of overall risk is genetic; certain types of cancer have additional risk.
- Loading...
Loading...
Next post in Urology
Loading... 
Loading...